• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHZ2100522 达格列净片 dapagliflozin Tablet Chemical Drugs License Renew 2021-04-19 AstraZeneca AB;Astrazeneca Investment (China) Co Ltd;Astrazeneca Pharmaceuticals Lp view
JYHZ2100521 达格列净片 dapagliflozin Tablet Chemical Drugs License Renew 2021-04-19 AstraZeneca AB;Astrazeneca Investment (China) Co Ltd;Astrazeneca Pharmaceuticals Lp view
JYHZ2100520 达格列净片 dapagliflozin Tablet Chemical Drugs License Renew 2021-04-19 AstraZeneca AB;Astrazeneca Investment (China) Co Ltd;Astrazeneca Pharmaceuticals Lp view
JYHZ2100519 达格列净片 dapagliflozin Tablet Chemical Drugs License Renew 2021-04-19 AstraZeneca AB;Astrazeneca Investment (China) Co Ltd;Astrazeneca Pharmaceuticals Lp view
JYHS2500023 达格列净二甲双胍缓释片(IV) dapagliflozin;metformin hydrochloride Tablet, extended release Chemical Drugs(5.2) Import Drug Application 2025-04-25 M/S Cipla Ltd;Cipla (China) Pharmaceutical Co Ltd view
JYHS2500022 达格列净二甲双胍缓释片(III) dapagliflozin;metformin hydrochloride Tablet, extended release Chemical Drugs(5.2) Import Drug Application 2025-04-25 M/S Cipla Ltd;Cipla (China) Pharmaceutical Co Ltd view
JYHS2500021 达格列净二甲双胍缓释片(I) dapagliflozin;metformin hydrochloride Tablet, extended release Chemical Drugs(5.2) Import Drug Application 2025-04-25 M/S Cipla Ltd;Cipla (China) Pharmaceutical Co Ltd view
JYHS2500020 达格列净二甲双胍缓释片(I) dapagliflozin;metformin hydrochloride Tablet, extended release Chemical Drugs(5.2) Import Drug Application 2025-04-25 M/S Cipla Ltd;Cipla (China) Pharmaceutical Co Ltd view
JYHS2400017 达格列净片 dapagliflozin Tablet Chemical Drugs(5.2) Import Drug Application 2024-04-17 Hetero Labs Ltd;Benova(Tianjin)Innovation Pharmaceutical Research Co Ltd view
JYHS2400016 达格列净片 dapagliflozin Tablet Chemical Drugs(5.2) Import Drug Application 2024-04-17 Hetero Labs Ltd;Benova(Tianjin)Innovation Pharmaceutical Research Co Ltd view
JYHS2300105 达格列净片 dapagliflozin Tablet Chemical Drugs(5.2) Import Drug Application 2023-08-19 Krka dd Novo Mesto;Ningbo Krka Menovo Pharmaceutical Co Ltd view
JYHS2200073 达格列净片 dapagliflozin Tablet Chemical Drugs(5.2) Import Drug Application 2022-07-22 Alembic Pharmaceuticals Ltd view
JYHS2200072 达格列净片 dapagliflozin Tablet Chemical Drugs(5.2) Import Drug Application 2022-07-22 Alembic Pharmaceuticals Ltd view
JYHS2101040 达格列净片 dapagliflozin Tablet Chemical Drugs(5.2) Import Drug Application 2021-09-15 Hetero Labs Ltd;Benova(Tianjin)Innovation Pharmaceutical Research Co Ltd view
JYHS2101039 达格列净片 dapagliflozin Tablet Chemical Drugs(5.2) Import Drug Application 2021-09-15 Hetero Labs Ltd;Benova(Tianjin)Innovation Pharmaceutical Research Co Ltd view
JYHS2101019 达格列净片 dapagliflozin Tablet Chemical Drugs(5.2) Import Drug Application 2021-07-06 M/S Cipla Ltd view
JYHB2500216 达格列净片 dapagliflozin Tablet Chemical Drugs(5.2) Supplementary Application 2025-04-12 M/S Cipla Ltd view
JYHB2500033 达格列净二甲双胍缓释片(Ⅰ) dapagliflozin;metformin hydrochloride Tablet, extended release Chemical Drugs(5.1) Supplementary Application 2025-01-24 AstraZeneca AB;Astrazeneca Pharmaceuticals Lp view
JYHB2500032 达格列净二甲双胍缓释片(Ⅰ) dapagliflozin;metformin hydrochloride Tablet, extended release Chemical Drugs(5.1) Supplementary Application 2025-01-24 AstraZeneca AB;Astrazeneca Pharmaceuticals Lp view
JYHB2101317 达格列净片 dapagliflozin Tablet Chemical Drugs Supplementary Application 2021-08-12 AstraZeneca AB;Astrazeneca Pharmaceuticals Lp view